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- Minimization of the metabolic burden  
- Develop of an antibiotic-free expression system, devoid of resistance markers 
- Improvement of the recombinant FucA production 
*Highlights (for review)









	   1	  
Using	  promoter	  libraries	  to	  reduce	  metabolic	  1	  
burden	  due	  to	  plasmid-­‐encoded	  proteins	  in	  2	  





Martina	  Pasini1,	  Alfred	  Fernández-­‐Castané2,	  Alfonso	  Jaramillo3,4,	  Carles	  de	  Mas1,	  Gloria	  8	  
Caminal5,	  Pau	  Ferrer1	  9	  
1	  Department	  of	  Chemical	  Engineering,	  Escola	  d’Enginyeria,	  Universitat	  Autònoma	  de	  Barcelona,	  10	  
Bellaterra	  (Cerdanyola	  del	  Vallès),	  Spain	  11	  
2	  School	  of	  Chemical	  Engineering,	  University	  of	  Birmingham,	  Edgbaston	  (Birmingham),	  UK	  12	  
3	  School	  of	  Life	  Sciences,	  University	  of	  Warwick,	  Coventry	  CV4	  7AL,	  United	  Kingdom	  13	  
4	  Institute	  of	  Systems	  and	  Synthetic	  Biology,	  Université	  d’Évry	  Val	  d’Essonne,	  CNRS,	  F-­‐91000	  Évry,	  14	  
France	  	  15	  





Corresponding	  autor:	  	  Martina	  Pasini	  21	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Martina.pasini@uab.cat	  22	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Tel.	  +34	  93	  581	  2695	  23	  



















	   2	  
Abstract	  33	  
The	  over-­‐expression	  of	  proteins	  in	  recombinant	  host	  cells	  often	  requires	  a	  significant	  amount	  of	  resources	  34	  
causing	  an	  increase	  in	  the	  metabolic	  load	  for	  the	  host.	  This	  results	  in	  a	  variety	  of	  physiological	  responses	  35	  
leading	  to	  altered	  growth	  parameters,	  including	  growth	  inhibition	  or	  activation	  of	  secondary	  metabolism	  36	  
pathways.	  Moreover,	  the	  expression	  of	  other	  plasmid-­‐encoded	  genes	  such	  as	  antibiotic	  resistance	  genes	  37	  
or	  repressor	  proteins	  may	  also	  alter	  growth	  kinetics.	  	  38	  
In	  this	  work,	  we	  have	  developed	  a	  second-­‐generation	  system	  suitable	  for	  Escherichia	  coli	  expression	  with	  39	  
an	   antibiotic-­‐free	   plasmid	   maintenance	   mechanism	   based	   on	   a	   glycine	   auxotrophic	   marker	   (glyA).	  40	  
Metabolic	  burden	  related	  to	  plasmid	  maintenance	  and	  heterologous	  protein	  expression	  was	  minimized	  by	  41	  
tuning	   the	   expression	   levels	   of	   the	   repressor	   protein	   (LacI)	   and	   glyA	   using	   a	   library	   of	   promoters	   and	  42	  
applying	   synthetic	  biology	   tools	   that	  allow	   the	   rapid	   construction	  of	   vectors.	   The	  engineered	  antibiotic-­‐43	  
free	  expression	  system	  was	  applied	  to	  the	  L-­‐fuculose	  phosphate	  aldolase	  (FucA)	  over-­‐production,	  showing	  44	  
an	  increase	  in	  production	  up	  to	  3.8	  fold	  in	  terms	  of	  FucA	  yield	  (mg·∙g-­‐1DCW)	  and	  4.5	  fold	  in	  terms	  of	  FucA	  45	  
activity	  (AU·∙g-­‐1DCW)	  compared	  to	  previous	  expression.	  Moreover,	  acetic	  acid	  production	  was	  reduced	  to	  46	  
50%,	  expressed	  as	  gAc·∙gDCW-­‐1.	  47	  
Our	   results	   showed	   that	   the	   aforementioned	   approaches	   are	   of	   paramount	   importance	   in	   order	   to	  48	  
increment	  the	  protein	  production	  in	  terms	  of	  mass	  and	  activity.	  	  49	   	  50	   	  51	   	  52	  
Keywords:	   Synthetic	   Biology,	   Golden	   Gate	   Assembly,	   recombinant	   protein	   production	   and	  53	  
Escherichia	  coli,	  bioprocess	  optimization	  54	   	  55	   	  56	   	  57	   	  58	   	  59	   	  60	   	  61	   	  62	   	  63	   	  64	   	  65	   	  66	   	  67	   	  68	  









	   3	  
Introduction	  69	   	  70	  
Among	  the	  many	  systems	  available,	  the	  gram	  negative	  bacterium	  Escherichia	  coli	  remains	  one	  of	  the	  most	  71	  
versatile	  and	  used	  host	  for	  the	  production	  of	  heterologous	  proteins,	  because	  of	  its	  rapid	  growth	  rate,	  the	  72	  
easiness	  to	  attain	  high	  cell	  density	  cultures	  on	  inexpensive	  substrates,	  its	  well-­‐characterized	  genetics	  and	  73	  
the	  availability	  of	  excellent	  genetic	  tools	  [1].	  Efforts	  in	  developing	  strategies	  to	  maximize	  the	  productivity	  74	  
of	  recombinant	  proteins	   in	  E.	  coli	  are	  well	  documented	   in	   the	   literature	   [2]	  and	  [3].	   	  Extensive	  research	  75	  
has	  been	  performed	  over	  the	  past	  years	  in	  order	  to	  improve	  recombinant	  protein	  production	  in	  this	  cell	  76	  
factory,	   including	   the	   optimization	   of	   process	   parameters	   such	   as	   growth	   temperature,	   media	  77	  
composition,	  induction	  conditions,	  as	  well	  as	  engineering	  novel	  expression	  systems	  [4]	  and	  [5].	  	  78	  
Recent	  advances	   in	  the	  synthetic	  biology,	  allowed	  the	  development	  of	  new	  methods	  and	  tools	  to	  speed	  79	  
up	   and	   standardize	   strain	   engineering.	   Compared	   with	   conventional	   DNA	   cloning	   protocols,	   these	  80	  
advanced	  DNA	  assembly	  strategies	  offer	  an	  efficient	  approach	  to	  construct	  multi-­‐gene	  pathways	  in	  a	  one-­‐81	  
step,	   scar-­‐less,	   and	   sequence-­‐independent	   manner.	   In	   particular,	   the	   Parts	   Registry	   is	   a	   collection	   of	  82	  
standardized	   biological	   parts	   (BioBricks)	   that	   allow	   the	   fast	   assembly	   of	   new	   functions	   [6],	   [7]	   and	   [8].	  83	  
Individual	  parts	  or	  combinations	  of	  parts	  that	  encode	  defined	  functions	  can	  be	  independently	  tested	  and	  84	  
characterized	   in	   order	   to	   improve	   the	   expression	   system	   [9].	   DNA	   construction	   based	   on	   the	   BioBrick	  85	  
theory	   has	   become	   a	   key	   part	   of	  most	  metabolic	   engineering	   projects	   and	   genetic	   circuits	   design.	   The	  86	  
BioBrick	   concept	   exploits	   the	   advantage	   that	   the	   same	   promoters,	   ribosome	   binding	   sites,	   expression	  87	  
tags,	  antibiotic	  resistances	  and	  origins	  of	  replication	  are	  frequently	  reused,	  with	  only	  the	  genes	  of	  interest	  88	  
being	  varied	  [7]	  and	  [8].	  	  89	  
Aldolases	   belong	   to	   the	   class	   of	   lyases,	  which	   catalyze	   C-­‐C	   bond	   formation	   leading	   to	   enantiomerically	  90	  
pure	   products,	   even	   when	   the	   starting	   materials	   are	   non-­‐chiral	   substrates.	   In	   particular,	   L-­‐Fuculose	  91	  
phosphate-­‐aldolase	   (FucA)	   catalyzes	   the	   reversible	   reaction	   of	   L-­‐fuculose-­‐1-­‐phosphate	   to	  92	  
dihydroxyacetone	  phosphate	  (DHAP)	  and	  L-­‐lactaldehyde	  in	  vivo.	  E.	  coli	  has	  been	  proven	  to	  be	  an	  efficient	  93	  
platform	   for	   soluble	   overexpression	   of	   a	   wide	   range	   of	   aldolases,	   both	   endogenous	   and	   from	   other	  94	  
bacteria	  [10]	  and	  [11].	  	  95	  
Vidal	   et	   al.	   [12]	   used	   rhamnulose	   1-­‐phosphate	   aldolase	   (RhuA)	   as	   a	   model	   protein	   to	   develop	   an	  96	  
auxotrophic	  marker-­‐based	  expression	  system	  consisting	  of	  the	  M15ΔglyA	  strain,	  with	  a	  genome	  deletion	  97	  
of	   the	  glyA	   gene,	   and	   a	   two-­‐plasmid	   system	   using	   the	   commercial	   pQE-­‐40	   (Qiagen)	   expression	   vector,	  98	  
which	   uses	   the	   stronger	   T5	   promoter	   [13].	   The	   E.	   coli	   glyA	   gene	   encodes	   for	   the	   enzyme	   serine	  99	  
hydroxymethyl	   transferase	   (SHMT),	  which	   catalyzes	   the	   reversible	   interconversion	  between	   L-­‐threonine	  100	  
and	   glycine	   and	   between	   serine	   and	   glycine	   [14].	   Although	   previous	   studies	   have	   shown	   that	   the	  101	  
auxotrophic	   glyA-­‐based	   expression	   vector	   is	   a	   promising	   alternative	   approach	   to	   the	   use	   of	   antibiotic	  102	  
selection	  markers	   [13],	   increased	  SMHT	   levels	   leads	   to	  a	  metabolic	  burden,	  which	  causes	  a	  decrease	   in	  103	  
activity	  and	  specific	  productivity	  of	   recombinant	  proteins	  compared	   to	   the	  original	   system.	  Besides,	   the	  104	  
presence	   of	   a	  metabolic	   load	   generally	   brings	   to	   a	   decreased	   level	   of	   energy	   available	   for	   a	   variety	   of	  105	  
cellular	  functions,	  i.e.	  for	  cell	  maintenance	  and	  growth.	  	  106	  









	   4	  
On	   the	   other	   hand,	   the	   use	   of	   a	   two-­‐plasmid	   expression	   system	   often	   requires	   the	   presence	   of	   their	  107	  
respective	   antibiotic	   markers	   and	   this	   fact	   is	   a	   limitation	   for	   the	   production	   of	   certain	   compounds	   of	  108	  
pharmaceutical	  or	  clinical	  interest.	  In	  our	  case	  study,	  it	  is	  of	  paramount	  importance	  to	  fine-­‐tune	  the	  glyA	  109	  
and	  lacI	  expression	  levels	  and	  to	  eliminate	  the	  pREP4	  plasmid	  in	  order	  to	  overcome	  these	  limitations	  and	  110	  
allow	  the	  development	  of	  an	  antibiotic-­‐free	  expression	  system.	  111	  
In	   this	   work,	   the	   FucA	   aldolase	   has	   been	   used	   as	   a	  model	   protein	   and	   its	   gene	   (fucA)	   has	   been	   firstly	  112	  
cloned	   into	   the	   Qiagen	   commercial	   expression	   system	   in	   order	   to	   obtain	   high	   intracellular	   expression	  113	  
levels.	   Secondly,	   through	   the	   application	   of	   different	   synthetic	   biology	   approaches,	   the	   design	   and	  114	  
construction	   of	   an	   M15/pQE40-­‐derived	   expression	   system	   consisting	   of	   a	   single	   vector	   is	   presented.	  115	  
Thirdly,	   the	   expression	   levels	   of	   the	   key	   genes	   lacI	   and	   glyA	   have	   been	   tuned	   by	   the	   use	   of	   different	  116	  
constitutive	   promoters.	   Finally,	   to	   completely	   avoid	   the	   presence	   of	   the	   antibiotic	   resistance	   gene,	  117	  
considered	  unacceptable	   in	  many	   areas	   of	   biotechnology	   by	   regulatory	   authorities	   [15],	   the	   expression	  118	  
system	  has	  been	  further	  engineered	  to	  be	  finally	  devoid	  of	  antibiotic	  resistance	  marker	  genes	  and	  tested	  119	  
for	  FucA	  production	  in	  shake	  flasks.	  120	  
	  121	  
Materials	  and	  methods	  122	  
	  123	  
Bacterial	  strains	  	  124	  
The	   bacterial	   strain	   K12-­‐derived	   E.	   coli	   M15	   (Qiagen)	   and	  M15ΔglyA	   were	   used	   for	   recombinant	   FucA	  125	  
expression.	  The	  strain	  E.	  coli	  DH5α	  was	  used	  for	  plasmid	  construction	  and	  propagation.	  The	  strains	  were	  126	  
stored	   at	   -­‐80°C	   in	   cryo-­‐stock	   aliquots	   prepared	   from	  exponential	   phase	   cultures	   grown	   in	   Luria-­‐Bertani	  127	  
(LB)	  medium.	  Bacterial	   strains	  used	   in	   this	  study	  are	  summarized	   in	  Table	  S1	   (Supplemented	  materials).	  128	  
While,	  abbreviation	  for	  all	  the	  E.coli	  strains	  used	  are	  summarized	  in	  Table	  S2	  (Supplemented	  materials).	  129	  
	  130	  
Molecular	  biology	  techniques	  131	  
Plasmid	  and	  strain	  constructions	  132	  
Plasmid	  DNA	  and	  DNA	  fragments	  were	  isolated	  or	  purified	  using	  PreYieldTM	  plasmid	  miniprep	  system	  and	  133	  
Wizard®	   SV	   gel	   and	   PCR	   clean-­‐up	   system	   (Promega)	   according	   to	   the	   manufacturer’s	   instructions.	  134	  
Restriction	   enzymes	   were	   purchased	   from	   Thermo	   Scientific	   and	   T4	   DNA	   ligase	   from	   Roche.	  135	  
Transformation	  of	  E.	  coli	  DH5α,	  M15	  and	  M15ΔglyA	  competent	  cells	  with	  the	  DNA	  ligation	  reactions	  was	  136	  
performed	   by	   electroporation	   using	   a	   GenePulser	   MXcellTM	   electroporator	   from	   Bio-­‐Rad,	   with	   a	   pulse	  137	  
(V=2500v;	   C=25	   μF;	   R=200	   Ω).	   Transformants	   were	   grown	   on	   LB-­‐agar	   medium	   or	   on	   defined	   medium	  138	  
(DM)-­‐agar	  plates	  supplemented	  with	  antibiotic,	  ampicillin	  and	  kanamycin	  with	  a	  final	  concentration	  of	  100	  139	  









	   5	  
mg·∙L-­‐1	  while	  the	  chloramphenicol	  30	  mg·∙L-­‐1).	  Transformant	  clones	  were	  confirmed	  by	  colony-­‐PCR,	  single	  or	  140	  
double	  restriction	  digests	  and	  DNA	  sequencing.	  141	  
	  142	  
PCR	  reactions	  143	  
For	   fragments	   up	   to	   2.0	   Kb,	   KOD	   Polymerase	   Novagen	   from	   Merck	   Biosciences	   was	   used	   whereas	  144	  
fragments	   >2.0	   Kb,	   Phusion	   high-­‐fidelity	   DNA	   polymerase	   (Thermo	   Scientific)	   was	   used,	   following	   the	  145	  
guidelines	   provided	   by	   the	   manufacturer,	   respectively.	   For	   the	   verification	   of	   ligation	   reactions	   and	  146	  
transformations,	  colony	  PCR	  was	  performed	  using	  the	  GoTaq®	  master	  mix	  (Promega).	  Primers	  are	  listed	  in	  147	  
Table	  S2	  (supplemented	  materials).	  148	  
Four	   promoters	   used	   (J23117,	   J23100,	   J23111	   and	   J23100)	   in	   this	   study	   and	   were	   selected	   from	   a	  149	  
combinatorial	   library	   of	   constitutive	   promoters	   (Registry	   for	   Standard	   Biological	   Parts,	  150	  
http//parts.igem.com).	   The	   strength	   of	   the	   promoters	   is	   calculated	   as	   the	   reported	   activities	   of	   red	  151	  
fluorescence	  protein,	  being	  the	  J23117	  the	  reference	  promoter,	  that	  is,	  with	  a	  given	  relative	  transcription	  152	  
efficiency	  of	  1	   (in	  arbitrary	  units).	   The	  promoters	   J23110,	   J23111	  and	   J23100	  are	  5.2,	  9.2	  and	  15.7	   fold	  153	  
strongest	   than	   J23117,	   respectively.	   Each	   promoter	   was	   synthetized	   by	   oligonucleotide	   hybridization	  154	  
including	  two	  BsaI	  sites	  with	  2	  different	  overhangs	  at	  both,	  5’	  and	  3’	  terminus.	  155	  
PCR,	  agarose	  gel	  electrophoresis	  and	  DNA	  sequencing	  were	  performed	  to	  check	  all	  the	  cloning	  reactions	  156	  
following	  routine	  protocols	  as	  described	  in	  Green	  and	  Sambrook	  [16].	  	  157	  
	  158	  
Plasmid	  constructs	  159	  
Plasmids	  used	  in	  this	  study	  are	  summarized	  in	  table	  S1	  (Supplemented	  materials).	  	  160	  
	  161	  
pQE-­‐FucA	  162	  
The	  commercial	  vector	  pQE-­‐40	  (Qiagen)	  was	  used	  as	  reference	  vector	  for	  the	  expression	  of	  the	  protein	  of	  163	  
interest,	  namely	  FucA.	  This	  expression	  vector	   is	  based	  on	  the	   IPTG-­‐inducible	  T5	  promoter,	  derived	  from	  164	  
the	  T5	  phage.	  	  This	  promoter	  is	  recognized	  by	  E.	  coli	  RNA	  polymerase,	  and	  has	  a	  double	  lac	  operator	  (lac	  165	  
O)	   repression	   module	   in	   series	   to	   provide	   tightly	   regulated	   and	   high-­‐level	   expression	   of	   recombinant	  166	  
proteins	   (Figure	   S1A).	   The	   fucA	   gene	   was	   amplified	   from	   the	   pTrcfuc	   vector	   using	   the	   FucA_FW	   and	  167	  
FucA_REW	   primers	   (Supplementary	   materials	   table	   S2).	   Thereafter,	   the	   0.65	   Kbp	   PCR	   fragment	   was	  168	  
digested	  with	  the	  restriction	  enzymes	  BamHI	  and	  HindIII	  and	  subsequently	  cloned	  into	  the	  linearized	  pQE-­‐169	  
40,	  yielding	  pQE-­‐FucA	  (Figure	  S1B).	  The	  final	  product	  was	  then	  transformed	  into	  E.	  coli	  M15	  [pREP4]	  cells.	  	  170	  
	  171	  
pQEαβFucA	  	  172	  
The	   DNA	   fragment	   comprising	   the	   glyA	   gene	   was	   amplified	   from	   pQEαβRham	   (designated	   as	  173	  
αβTerminator)	   [13],	   including	   the	   promoter	   and	   the	   3’	   termination	   region.	   The	   resulting	   1,784	   Kbp	  174	  









	   6	  
fragment	   was	   then	   digested	   with	   BspEI	   and	   XbaI	   and	   subsequently	   ligated	   into	   pQE-­‐FucA	   to	   obtain	  175	  
pQEαβFucA	  (Figure	  S1C).	  The	  ligation	  reaction	  was	  transformed	  into	  E.	  coli	  M15ΔglyA[pREP4].	  	  	  	  176	   	  177	  
BioBrick-­‐based	  vectors	  (pSB1C3-­‐J231XX-­‐lacI-­‐glyA)	  	  178	  
The	  BioBrick	  vectors	  were	  assembled	  using	  the	  golden	  gate	  technique	  [17].	  This	  strategy	  exploit	  the	  ability	  179	  
of	  type	  IIs	  endonucleases	  to	  cleave	  DNA	  outside	  the	  recognition	  site	  leaving	  an	  overhang	  sequence.	  In	  this	  180	  
study	  BsaI	  restriction	  enzyme	  and	  four	  nucleotide	  overhangs	  is	  used.	  	  181	  
Both	  the	   lacI	  and	  glyA	  genes	  were	  PCR-­‐amplified	  and	  were	  made	  compatible	  for	  the	  construction	  of	  the	  182	  
BioBrick	   vectors.	   The	   lacI	   gene	   was	   amplified	   from	   the	   pREP4	   plasmid	   with	   the	   GG_lacI_FW	   and	  183	  
GG_lacI_REW	   primers	   and	   a	   de	   novo	   strong	   RBS	   sequence	   (BBa_B0034,	  184	  
http://parts.igem.org/Part:BBa_B0034)	   was	   introduced	   (Indicated	   in	   red	   in	   Table	   S2).	   The	   DNA	   part	  185	  
containing	  the	  glyA	  gene	  was	  obtained	  from	  pQEαβRham	  using	  GG_glyA_FW	  and	  GG_glyA_REW	  primers	  186	  
comprised	  with	  a	   strong	  RBS	  sequence	   (BBa_J61100,	  http://parts.igem.org/Part:BBa_J61100),	  being	   this	  187	  
RBS	  sequence	  different	  to	  the	  lacI	  gene	  in	  order	  to	  avoid	  homologous	  recombination	  (Indicated	  in	  green	  188	  
in	   Table	   S2).	   The	   terminator	   sequence	   was	   maintained	   from	   the	   glyA	   native	   region,	   which	   was	   PCR-­‐189	  
amplified	  from	  chromosomal	  E.	  coli	  K-­‐12	  [13].	  BsaI	  sites	  with	  two	  overhangs	  were	  introduced	  at	  the	  5’	  and	  190	  
3’	  prime	  in	  all	  assembled	  fragments	  to	  provide	  directional	  cloning	  and	  to	  prevent	  the	  religation	  of	  empty	  191	  
vector.	  All	  reaction	  DNA	  fragments	  were	  prepared	  equimolar	  to	  a	  concentration	  of	  69	  fmol·∙μL-­‐1.	  To	  each	  192	  
reaction,	   0.5	  μL	  of	  BsaI	   and	  T4	   ligase	  were	   added.	   Final	   reactions	  were	   incubated	   in	   a	   thermocycler	   as	  193	  
follows:	   25-­‐30	   cycles	   (37	   °C,	   3	  min;	   16	   °C,	   4	  min)	   and	   final	   step	   50	   °C,	   5	  min	   and	   80	   °C,	   5	  min.	   Thus,	  194	  
reactions	   were	   performed	   in	   one-­‐step	   restriction-­‐ligation	   (Figure	   1A).	   Four	   BioBrick	   constructs	   were	  195	  
assembled,	  each	  one	  with	  a	  different	  constitutive	  promoter	  to	  tune	  the	  expression	  levels	  of	  lacI	  and	  glyA	  196	  
genes.	  The	  four	  vectors	  were	  named	  pSB1C3-­‐J231XX,	  where	  the	  double	  X	  represents	  the	  last	  two	  digits	  of	  197	  
the	  promoter	  name	  (Figure	  1B).	  Finally,	  2-­‐5	  μL	  of	  assembly	  BioBrick	  constructs	  were	  transformed	  into	  50	  198	  
μL	  of	  E.	  coli	  DH5α.	  	  199	  
	  200	  
pQE-­‐FucA_puzzle	  (J23110)	  201	  
The	   construction	   of	   vector	   derived	   from	   the	   pQE-­‐FucA	   and	   the	   BioBrick	   vectors	   required	   a	   two-­‐step	  202	  
assembly.	   The	   expression	   cassette	   J23110-­‐lacI-­‐glyA	   was	   amplified	   from	   pSB1C3-­‐J23110-­‐lacI-­‐glyA	   using	  203	  
PJ/2_FW	  and	  PJ_REW	  primers.	   Both,	   PCR	  product	   and	  destination	   vector	  pQE-­‐FucA	  were	  digested	  with	  204	  
Bpu10I	  and	  MscI	  and	  subsequently	  extracted	  from	  agarose	  gel.	  The	  expression	  cassette	  was	  cloned	   into	  205	  
the	  pQE-­‐FucA	  (double	  digested)	  obtaining	  the	  pQE-­‐FucA_puzzle	  (J23110)	  (Figure	  S2A).	  Finally,	  the	  ligation	  206	  
product	  was	  transformed	  into	  the	  M15ΔglyA	  generating	  M15ΔglyA	  pQE-­‐FucA_puzzle	  (J23110),	  from	  now	  207	  













	   7	  
pQE-­‐FucA_puzzle	  (J23110)_AmpR−	  	  212	  
Vector	  pQE-­‐FucA_puzzle	   (J23110)	  was	  double	  digested	  with	  Eco0109I	  and	  Ahdl	   in	  order	   to	  eliminate	  de	  213	  
bla	  gene.	  	  5´-­‐3´polymerase	  and	  3´-­‐5´exonuclease	  activities	  of	  DNA	  Polymerase	  I	  (Large)	  Klenow	  Fragment	  214	  
was	  used	  in	  order	  to	  end-­‐removal	  and	  fill-­‐in	  terminal	  unpaired	  nucleotides.	  215	  
The	  blunting	  DNA	  reaction,	  composed	  of	  digested	  vector	  0.5	  mg,	  1	  μL	  of	  dNTPS	  25	  mM	  (Bioline)	  and	  1	  μL	  216	  
of	  DNA	  polymerase	  I	  (5U/μL)	  (NEB),	  was	  incubated	  at	  room	  temperature	  (RT)	  20	  min,	  followed	  by	  a	  heat	  217	  
inactivation	   step	   at	   75	   °C	   10	   min.	   The	   ligation	   reaction	   of	   the	   blunt	   ended	   DNA	   fragments	   and	   their	  218	  
respective	  plasmid	  backbones	  were	  carried	  out	  at	  16	  °C	  overnight	  using	  T4	   ligase.	  The	  resulting	   ligation	  219	  
(Figure	  S2B)	  vector	  was	   transformed	   into	  E.	   coli	  M15ΔglyA	   and	  plated	  on	  defined	  medium	  (DM)	  plates,	  220	  
generating	  M15ΔglyA	  pQE-­‐FucA_puzzle	  (J23110)_	  AmpR-­‐,	  from	  now	  on	  AmpR-­‐	  strain.	  Transformants	  were	  221	  
isolated	  and	  tested	  both,	   in	  DM	  and	  LB	  supplemented	  with	  ampicillin	  plates,	  as	  a	  positive	  and	  negative	  222	  
control,	   respectively.	   Selected	   transformants	   were	   able	   to	   grow	   in	   defined	  media	   but	   not	   in	   LB	   plates	  223	  
supplemented	  with	  ampicillin.	  Positive	  clones	  were	  validated	  as	  described	  previously.	  	  224	  
	  225	  
Culture	  media	  226	  
Luria	  Bertani	  (LB)	  medium,	  containing	  10	  g·∙L-­‐1	  peptone,	  5	  g·∙L-­‐1	  yeast	  extract	  and	  10	  g·∙L-­‐1	  NaCl,	  was	  used	  for	  227	  
pre-­‐cultures.	  228	  
	  229	  
Defined	  Medium	  (DM)	  used	  for	  shake	  flasks	  cultures	  contained	  per	  liter:	  5	  g	  glucose,	  2.97	  g	  K2HPO4,	  0.60	  g	  230	  
KH2PO4,	   0.46	   g	   NaCl,	   0.75	   g	   (NH4)2SO4,	   0.11	   g	   MgSO4·∙7H2O,	   0.006	   g	   FeCl3,	   0.025	   g	   thiamine,	   1.44	   g	  231	  
CaCl2·∙2H2O,	   0.07	  mL·∙100mL
-­‐1	  medium	   of	   trace	   elements	   solution	   (TES)	   (TES	   contained	   per	   liter:	   0.04	   g	  232	  
AlCl3·∙6H2O,	  1.74	  g	  ZnSO4·∙7H2O,	  0.16	  g	  CoCl2·∙6H2O,	  2.18	  g	  CuSO4·∙5H2O,	  0.01	  g	  H3BO3,	  1.42	  g	  MnCl2·∙6H2O,	  233	  
0.01	  g	  NiCl2·∙6H2O,	  0.23	  g	  Na2MoO4·∙5H2O).	  Agar	  plates	  prepared	  with	  DM	  contained	  1.5%	  Agarose.	  234	  
Stock	   solutions	  of	   kanamycin	  and	   chloramphenicol	  were	  prepared	  with	  a	   concentration	  of	  100	  mg·∙mL-­‐1	  235	  
and	  30	  mg·∙mL-­‐1,	  respectively,	  and	  stored	  at	  -­‐20	  °C.	  Ampicillin	  100	  mg·∙L-­‐1	  ethanol	  stock	  was	  prepared	  and	  236	  
stored	  at	  -­‐20	  °C.	  IPTG	  stock	  was	  prepared	  at	  100	  mM,	  and	  stored	  at	  -­‐20	  °C.	  237	  
Vitamins,	  antibiotics,	  TES,	  FeCl3,	  MgSO4·∙4H2O,	  CaCl2·∙2H2O	  and	  inducer	  were	  sterilized	  by	  filtration	  (0.2	  µm	  238	  
syringe	   filter	   made	   from	   a	   blend	   of	   cellulose	   esters,	   Sartorius).	   Glucose	   and	   saline	   solutions	   were	  239	  
separately	  sterilized	  by	  autoclaving	  at	  121°C	  for	  30	  min.	  240	  
	  241	  
Cultivation	  conditions	  242	  
Pre-­‐inoculum	  243	  
Cryo-­‐stocks	  stored	  at	  -­‐80°C,	  were	  use	  to	  inoculate	  Falcon	  tubes	  with	  15	  mL	  of	  LB	  medium	  supplemented	  244	  
with	  the	  corresponding	  antibiotic	  if	  necessary.	  Growth	  was	  performed	  overnight	  at	  37	  °C	  with	  agitation.	  245	  
Cultures	  246	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Three	   mL	   of	   overnight	   pre-­‐inoculum	   were	   transferred	   into	   shake	   flasks	   containing	   100	   mL	   of	   DM,	  247	  
following	   the	   same	   growing	   conditions	   as	   pre-­‐inoculum	   cultures.	   All	   cultivations	   were	   performed	   in	   a	  248	  
working	  volume	  of	  100	  mL	   in	  500	  mL	  volume-­‐baffled	  shake	   flasks.	  To	   induce	   fucA	  expression,	   IPTG	  was	  249	  
added	  to	  a	  final	  concentration	  of	  1	  mM,	  when	  an	  OD600	  of	  1.5	  was	  reached.	  The	  induction	  was	  maintained	  250	  
for	  4	  hours,	  sampling	  before	  induction	  and	  1,	  2	  and	  4	  hours	  after	  induction.	  	  251	  
	  252	  
Analytical	  methods	  	  	  253	  
Cell	   concentration	   was	   determined	   by	   optical	   density	   (OD600)	   measurements	   at	   600	   nm	   using	   a	  254	  
spectrophotometer	   (Uvicon	   941	   Plus,	   Kontrol).	   OD	   values	   were	   converted	   to	   biomass	   concentration	  255	  
expressed	  as	  Dry	  Cell	  Weight	  (DCW),	  being	  1	  OD600	  equivalent	  to	  0.3	  gDCW·∙L
-­‐1	  [18].	  	  256	  
	  257	  
Glucose	   and	   acetate	   concentration	   were	   analysed	   in	   the	   broth.	   One	   milliliter	   of	   culture	   medium	   was	  258	  
separated	  from	  biomass	  by	  centrifugation	  at	  14.000	  rpm	  6	  min	  and	  filtered	  (0.45	  µm	  membrane	  filter	  of	  259	  
cellulose	  esters,	  Millipore)	  prior	   to	  analysis.	  Glucose	  concentration	  was	  determined	  enzymatically	  on	  an	  260	  
YSI	   2070	   system	   (Yellow	   Spring	   System).	   Acetic	   acid	   was	   analyzed	   by	   HPLC	   (Hewlett	   Paackard	   1050)	  261	  
equipped	  with	  an	   ICSep	  COREGEL	  87H3	   ICE-­‐99-­‐9861	   (Transgenomic)	   column	  and	   IR	  detector	   (HP	  1047),	  262	  
using	  6	  M	  H2SO4	  (pH	  2.0)	  as	  mobile	  phase,	  flow	  rate	  of	  0.3	  ml·∙min
-­‐1,	  at	  40	  °C.	  263	  
The	  biomass	  yield,	  YX/S	  was	  calculated	  using	  the	  following	  equation:	  264	  
𝑌!/! = (!"#!"#!!"#!)(!"#!!!"#) 	   	  	  	  	  [1]	  265	  
	  266	  
where,	  DCWmax	  and	  DCW0	  (g·∙L
-­‐1)	  are	  the	  maximum	  and	  the	   initial	  biomass	  values,	   respectively.	  Glc0	  and	  267	  
Glcf	  (g·∙L
-­‐1)	  are	  initial	  and	  final	  value	  of	  glucose	  concentration,	  respectively.	  268	  
The	  specific	  substrate	  uptake	  rate,	  qS,	  is	  defined	  as	  follows:	  269	  
𝑞! = !!!/!	   	  [2]	  270	  
	  271	  
where,	  qS	  is	  given	  as	  grams	  of	  carbon	  per	  grams	  of	  biomass	  per	  hour	  (g·∙g
-­‐1DCW·∙h-­‐1).	  272	  
	  273	  
The	  maximum	  specific	  growth	  rate	  (μmax)	  of	  the	  different	  strains	  is	  calculated	  by	  taking	  the	  natural	  log	  of	  274	  
the	  cell	  concentration	  and	  plotting	  it	  over	  time.	  The	  equation	  [3]	  shows	  the	  relationship	  between	  the	  cell	  275	  
concentration	  (X),	  maximum	  specific	  growth	  rate	  (μmax)	  and	  time	  (t).	  Log-­‐linearized	  Eq.	  [3]	  yields	  a	  linear	  276	  
relationship	  where	  the	  μmax	  is	  represented	  by	  the	  slope	  of	  the	  linear	  portion	  in	  the	  plot	  of	  the	  natural	  log	  277	  
of	  cell	  concentration	  versus	  time.	  278	  
	  279	   𝑋! = 𝑋! ∙ 𝑒!!"#∙!	   [3]	  280	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𝑙𝑛𝑋! = 𝑙𝑛𝑋! + 𝜇!"# ∙ 𝑡	  	  	  	  	  	  	  [4]	  281	  
where,	  Xt	  and	  X0	  are,	   in	   the	   linear	  zone,	   the	  OD600	  or	   the	  cell	   concentration	  at	  any	   time	   (t)	  and	  at	   the	  282	  
beginning,	  respectively.	  283	  
	  284	  
FucA	  quantification	  285	  
Samples	   from	   culture	   broths	   were	   withdrawn,	   adjusted	   to	   a	   final	   OD600	   of	   3,	   centrifuged	   and	   then	  286	  
processed	  as	  previously	  described	  [19]	  and	  [13].	  Briefly,	  pellets	  were	  resuspended	  in	  100	  mM	  TrisHcl	  (pH	  287	  
7.5).	  Cell	  suspensions	  were	  placed	  in	  ice	  and	  sonicated	  over	  four	  pulses	  of	  15	  seconds	  each	  at	  50W	  with	  2	  288	  
minutes	  intervals	  in	  ice	  between	  each	  pulse,	  using	  a	  VibracellTM	  model	  VC50	  (Sonics	  &	  Materials).	  Cellular	  289	  
debris	  were	  then	  removed	  by	  centrifugation	  and	  the	  cleared	  supernatant	  was	  collected	  for	  FucA	  analysis.	  290	  
One	  unit	  of	  FucA	  activity	   is	  defined	  as	  the	  amount	  of	  enzyme	  required	  to	  convert	  1	  μmol	  of	  fuculose-­‐1-­‐291	  
phosphate	   in	  DHAP	  and	  L-­‐lactaldehyde	  for	  minute	  at	  25	  °C	  and	  pH	  7.5	  [13].	   	  To	  quantify	  the	  amount	  of	  292	  
FucA	  relative	  to	  total	  intracellular	  soluble	  proteins,	  SDS-­‐PAGE	  and	  Bradford	  protein	  assay	  were	  performed	  	  293	  
Average	   values	   were	   plotted	   with	   error	   bars.	   The	   error	   indicates	   the	   confidence	   interval	   with	   a	  294	  




Comparison	  of	  FucA	  expression	  between	  M15[pREP4]	  and	  M15[pREP4]	  ΔglyA	  strain	  299	  
Preliminary	  experiments	  between	  E.	  coli	  M15[pREP4]	  pQE-­‐FucA	  and	  E.	  coli	  M15ΔglyA[pREP4]	  pQEαβFucA	  300	  
were	  performed	  in	  shake	  flask	  cultures	  in	  defined	  media	  (DM).	  Figures	  2A	  and	  2B	  compare	  biomass	  and	  301	  
FucA	  production	  profiles	  along	  time,	  for	  the	  M15[pREP4]	  and	  the	  M15ΔglyA[pREP4]	  strains,	  respectively.	  302	  
The	  reference	  M15[pREP4]	  strain	  presents	  a	  slightly	  higher	  maximum	  specific	  growth	  rate	  (μmax)	  of	  0.49	  ±	  303	  
0.01	  h-­‐1	  compared	  to	  0.44	  ±	  0.01	  h-­‐1	  in	  M15ΔglyA[pREP4].	  Moreover,	  Figures	  2C	  and	  2D	  present	  glucose	  304	  
consumption	  and	  acetate	  production	  profiles	  along	  time,	  for	  the	  M15[pREP4]	  and	  the	  M15ΔglyA[pREP4]	  305	  
strains,	   respectively.	   Substrate	   uptake	   rates	   (qS)	   along	   the	   induction	   phase	   for	   both	   strains	   were	  306	  
calculated,	   being	   0.37	   ±	   0.04	   and	   0.50	   ±	   0.13	   gGlc·∙g-­‐1DCW·∙h-­‐1	   for	   the	   M15[pREP4]	   and	   for	   the	  307	  
M15ΔglyA[pREP4],	  respectively.	  Moreover,	  whereas	  the	  M15[pREP4]	  strain	  reached	  a	  final	  production	  of	  308	  
181	  ±	  5	  mgFucA·∙g-­‐1DCW,	  with	  an	  activity	  of	  721	  ±	  82	  AU·∙g-­‐1DCW,	  these	  values	  were	  reduced	  to	  67	  ±	  37	  309	  
mgFucA·∙g-­‐1DCW	  291	  ±	  24	  AU·∙g-­‐1DCW	  respectively,	  in	  the	  M15ΔglyA[pREP4]	  strain	  (Figure	  2A-­‐B).	  310	  
Figure	   2E	   and	   2F	   represented	   the	   SDS-­‐PAGE	   for	   the	   M15[pREP4]	   and	   the	   M15ΔglyA[pREP4]	   strains,	  311	  
respectively.	   It	  can	  be	  clearly	  seen	  an	  increase	  in	  the	  SHMT	  band	  in	  the	  M15ΔglyA[pREP4]	  strain	  (Figure	  	  312	  









	   10	  
2F).	  Moreover,	   in	   Table	   1	   it	   can	   be	   seen	   how	   the	   SHMT	   values	   of	   the	  M15ΔglyA[pREP4]	   strain,	   being	  313	  
around	   90	   mgSHMT·∙g-­‐1DCW,	   increased	   comparing	   with	   the	   M15[pREP4]	   strain,	   being	   around	   20	  314	  
mgSHMT·∙g-­‐1DCW.	  	  315	  
	  316	  
pREP4	  elimination	  317	  
In	   order	   to	   obtain	   an	   expression	   system	   completely	   devoid	   of	   antibiotic	   resistance	   genes,	   we	   initially	  318	  
focused	  on	  the	  elimination	  of	  the	  pREP4	  plasmid.	  The	  objectives	  were	  to	   i)	  obtain	  an	  expression	  system	  319	  
based	  on	  a	  single	  plasmid;	  ii)	  clone	  the	  lacI	  gene	  from	  the	  pREP4	  plasmid	  to	  the	  pQE-­‐expression	  vector.	  	  320	  
Accordingly,	  the	  pREP4	  plasmid	  was	  eliminated	  from	  the	  M15ΔglyA[pREP4]	  pQEαβFucA	  system,	  obtaining	  321	  
the	   derived	   strain	  M15ΔglyA[A].	   Shake	   flask	   cultures	   were	   performed	   in	   defined	  media	   supplemented	  322	  
with	   ampicillin	   (data	   not	   shown).	   An	   increase	   in	   the	   basal	   FucA	   production	   was	   expected,	   due	   to	   the	  323	  
removal	  of	  the	  repressor	  protein	  encoded	  by	  the	   lacI	  gene	  present	  on	  the	  pREP4	  plasmid.	  Strikingly,	  no	  324	  
FucA	  production	  was	  detected	  in	  these	  cultures.	  To	  further	  understand	  this	  effect,	  the	  lacI	  gene	  from	  the	  325	  
pREP4	  was	  amplified	  and	  cloned	  into	  the	  pQEαβFucA	  plasmid,	  obtaining	  the	  pQE-­‐lacI-­‐αβFucA	  expression	  326	  
vector.	  Then,	  shake	  flask	  cultures	  were	  performed	  with	  M15ΔglyA[B]	  strain	  harboring	  this	  plasmid	  (data	  327	  
not	   shown).	   However,	  FucA	   expression	  was	   not	   found.	   In	   order	   to	   ensure	   there	   was	   no	   loss	   of	   the	  328	  
expression	  vector	  from	  the	  cells,	  the	  plasmid	  segregational	  stability	  was	  carried	  out	  at	  different	  cultivation	  329	  
times	  before	  and	  after	  induction.	  The	  experiments	  confirmed	  that	  the	  M15ΔglyA[B]	  cells	  maintained	  the	  330	  
expression	  vector	  and,	  consequently,	  the	  lack	  of	  FucA	  expression	  was	  not	  the	  result	  of	  plasmid	  loss.	  	  331	  
As	  mentioned	  in	  the	  Materials	  and	  Methods	  section,	  the	  T5	  promoter	  has	  a	  double	  lac	  O	  region	  in	  order	  332	  
to	  guarantee	  a	  strong	  repression	  under	  non-­‐induction	  conditions.	  The	   lac	  repressor,	  encoded	  by	  the	   lacI	  333	  
gene,	   binds	   very	   tightly	   to	   the	   promoter	   and	   ensures	   efficient	   repression	   of	   the	   strong	   T5	   promoter	  334	  
interfering	   with	   the	   transcription	   of	   the	   gene	   of	   interest.	   In	   order	   to	   further	   understand	   whether	   the	  335	  
promoter	  leakiness	  in	  the	  absence	  of	  repressor	  is	  due	  to	  structural	  instability,	  T5	  promoter	  region	  isolated	  336	  
from	  several	  non-­‐producing	  M15ΔglyA[A]	  constructs	  was	  sequenced.	  Interestingly,	  a	  deletion	  in	  the	  lac	  O	  337	  
regions	  was	  observed,	  probably	  due	  to	  recombination	  events	  in	  the	  homology	  region	  (data	  not	  shown).	  338	  
	  339	  
Tuning	  of	  lacI	  and	  glyA	  expression	  levels	  340	  
A	  series	  of	   FucA	  expressing	   strains	  presenting	  4	  different	   constitutive	   transcriptional	   levels	  of	   lacI	  were	  341	  
constructed.	  Moreover,	  because	  the	  first	  generation	  of	  glyA-­‐based	  auxotrophic	  system	  contained	  the	  glyA	  342	  
gene	  under	  the	  control	  of	  the	  P3	  constitutive	  promoter,	  resulting	  in	  relatively	  high	  amounts	  of	  its	  product,	  343	  
the	  same	  set	  of	  4	  promoters	  were	  tested	  to	  reduce	  the	  transcriptional	  levels	  of	  the	  glyA	  gene	  (Vidal	  L	  et	  344	  
al.,	  2008).	  Thus,	  an	  expression	  cassette	  was	  settled	  where	  the	  lacI	  and	  glyA	  genes	  were	  cloned	  under	  the	  345	  
control	  of	  the	  four	  constitutive	  promoters.	  	  346	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The	  aim	  was	  to	   find	  the	  suitable	  promoter	  with	  strength	  enough	  to	  synthetize	  the	  minimum	  amount	  of	  347	  
LacI	   inhibitor	   molecules	   preventing	   “promoter	   leakiness”,	   as	   well	   as	   the	   minimal	   glyA	   transcriptional	  348	  
levels	  required	  to	  maintain	  plasmid-­‐bearing	  cells	  and	  optimal	  cell	  growth	  in	  defined	  media.	  	  349	  
The	   four	   resulting	   expression	   vectors	  were	   co-­‐transformed	  with	   the	   pQE-­‐FucA	   plasmid	   into	  M15ΔglyA.	  350	  
The	   four	   expression	   systems	   generated	   were	   named	   M15ΔglyA[C00],	   [C11],	   [C10]	   and	   [C17]	   strains.	  351	  
Biomass	  and	  enzyme	  production	  were	  analyzed	  along	  time	  and	  are	  presented	  in	  Figure	  3A,	  3B,	  3C	  and	  3D,	  352	  
for	  M15ΔglyA[C00],	  M15ΔglyA[C11],	  M15ΔglyA[C10]	  and	  M15ΔglyA[C17]	  strains,	  respectively.	  353	  
The	  μmax	  measured	  in	  the	  different	  cultures	  for	  the	  M15ΔglyA[C11],	  M15ΔglyA[C10]	  and	  M15ΔglyA[C17]	  354	  
transformants	   were	   0.37	   ±	   0.01	   h-­‐1,	   0.48	   ±	   0.01	   h-­‐1	   and	   0.41	   ±	   0.01	   h-­‐1,	   respectively	   (Table	   2).	  	  355	  
M15ΔglyA[C00]	   strain	   presented	   significantly	   higher	   μmax	   being	   0.62	   ±	   0.05	   h
-­‐1	   (Table	   2).	   The	   over-­‐356	  
expression	  of	  FucA	  for	  the	  4	  selected	  transformants.	  The	  M15ΔglyA[C10]	  results	  the	  strain	  with	  the	  higher	  357	  
production	   both	   in	   term	   of	   mass	   and	   activity,	   being	   83	   ±	   7	   mg·∙g-­‐1DCW	   and	   574	   ±	   49	   AU·∙g-­‐1DCW,	  358	  
respectively	  (Figure	  3C).	  	  359	  
On	   the	   other	   hand,	   Table	   2	   and	   Figure	   4	   presents	   the	   glucose	   consumption	   and	   acetate	   production	  360	  
profiles	   along	   time	   for	   the	   4	   strains:	   4A,	   4B,	   4C	   and	   4D,	   for	   M15ΔglyA[C00],	   M15ΔglyA[C11],	  361	  
M15ΔglyA[C10]	  and	  M15ΔglyA[C17],	  respectively.	  It	  can	  be	  observed	  that	  the	  higher	  qS	  value,	  being	  0.79	  ±	  362	  
0.10	  g·∙g-­‐1DCW·∙h-­‐1,	  belongs	  to	  the	  M15ΔglyA[C00]	  strain,	  with	  an	  acetate	  production	  of	  1.50	  ±	  0.10	  gAc·∙g-­‐363	  
1DCW.	  While	  the	  M15ΔglyA[C10]	  strain	  presents	  the	  lower	  acetate	  amount	  of	  0.70	  ±	  0.12	  gAc·∙g-­‐1DCW.	  364	  
	  365	  
Expression	  vector	  optimization	  366	  
The	   M15ΔglyA[C11]	   was	   previously	   selected	   as	   the	   strain	   with	   highest	   FucA	   production	   and	   specific	  367	  
activity	  among	  the	  4	  different	  constructs.	  To	   further	  optimize	   the	  expression	  system,	   the	  next	  goal	  was	  368	  
the	   construction	   of	   a	   single	   vector	   harboring	   both	   the	   fucA	   gene	   under	   control	   of	   the	   inducible	   T5	  369	  
promoter	   and	   the	   lacI-­‐glyA	   cassette	   cloned	  under	   the	   J23110	   constitutive	   promoter.	   Such	  plasmid	  was	  370	  
constructed	  as	  described	   in	  Materials	  and	  Methods	  section	  and	   transformed	   into	  M15ΔglyA,	   yielding	  E.	  371	  
coli	  M15ΔglyA	  pQE-­‐FucA_puzzle	  (J23110)	  from	  now	  on	  Puzzle	  strain.	  372	  
The	  μmax	  of	  the	  Puzzle	  strain	  was	  0.45	  ±	  0.01	  h
-­‐1.	  Maximum	  FucA	  mass	  and	  FucA	  specific	  activity	  reached	  373	  
were	  162	  ±	  7	  mg-­‐1	  FucA·∙g-­‐1DCW	  and	  984	  ±	  35	  AU·∙g-­‐1DCW,	  respectively	  (Figure	  5A).	  Besides,	  the	  amount	  of	  374	  
acetate	  production	  for	  the	  Puzzle	  strain	  results	  0.42	  ±	  0.03	  g·∙g-­‐1DCW.	  	  375	  
Furthermore,	   in	   Table	   1,	   SHMT	   values	   are	   presented,	   being	   66	   ±	   17,	   62	   ±	   10,	   54	   ±	   14	   and	   54	   ±	   7	  376	  
mgSHMT·∙g-­‐1DCW,	  for	  the	  PI,	  1h,	  2h	  and	  4h	  induction	  samples,	  respectively.	  377	   	  378	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Development	  of	  an	  antibiotic-­‐free	  plasmid	  maintenance	  379	  
Lastly,	   an	   expression	   system	   completely	   devoid	   of	   antibiotic	   resistance	   genes	   was	   constructed	   by	  380	  
removing	  the	  bla	  gene	  from	  the	  expression	  vector	   (Figure	  S2B).	  The	  corresponding	  strain	  was	  named	  E.	  381	  
coli	  M15ΔglyA	  pQE-­‐FucA_puzzle	  (J23110)_AmpR-­‐,	  so-­‐called	  AmpR-­‐	  strain.	  	  382	  
Shake	  flasks	  cultures	  were	  performed	  in	  fined	  medium	  (DM)	  without	  any	  antibiotic	  supplementation.	  The	  383	  
time-­‐profiles	   of	   the	   biomass,	   glucose	   consumption,	   acetate	   and	   FucA	   (mass	   and	   specific	   activity)	  were	  384	  
analyzed.	  Results	  are	  presented	  in	  Figure	  6.	  The	  μmax	  was	  calculated	  being	  μmax	  0.41	  ±	  0.01	  h
-­‐1.	  In	  terms	  of	  385	  
FucA	  production,	  the	  point	  of	  maximum	  activity	  corresponds	  to	  1309	  ±	  42	  AU·g-­‐1DCW	  with	  a	  production	  386	  
in	  mass	  of	  219	  ±	  5	  mgFucA·g-­‐1DCW	  after	  4	  h	  of	  induction	  (Figure	  6A).	  Finally,	  SHMT	  values	  were	  calculated	  387	  
for	  each	   time	  point	  of	   induction.	  The	   results	  are	  presented	   in	  Table	  1,	  where	   the	  pre	   induction	   sample	  388	  




In	   the	  present	  work,	  we	  have	   further	  developed	  a	  novel	   expression	   system	  based	  on	  an	  antibiotic-­‐free	  393	  
plasmid	  maintenance	  mechanism.	  Our	  stepwise	  design	  approach	  resulted	  in	  increased	  production	  levels,	  394	  
up	   to	   3.8-­‐fold	   in	   terms	   of	   FucA	   yield	   (mg·∙g-­‐1DCW)	   and	   4.5-­‐fold	   in	   terms	   of	   FucA	   activity	   (AU·∙g-­‐1DCW),	  395	  
compared	  to	  the	  reference	  M15[pREP4]	  expression	  system.	  396	  
The	   comparison	   between	   the	   reference	   M15[pREP4]	   and	   the	   M15ΔglyA[pREP4]	   E.	   coli	   strains	  397	  
demonstrated	  that	  the	  later	  presents	  slightly	  lower	  specific	  growth	  rate,	  decreasing	  from	  0.49	  ±	  0.01	  h-­‐1,	  398	  
of	  the	  reference	  strain,	  to	  0.44	  ±	  0.01	  h-­‐1	  of	  the	  M15ΔglyA[pREP4]	  strain.	  This	  effect	  may	  be	  caused	  by	  the	  399	  
increase	  in	  the	  metabolic	  burden	  due	  to	  the	  maintenance	  of	  the	  expression	  vector	  in	  the	  M15ΔglyA	  strain.	  400	  
The	  presence	  of	  the	  glyA	  gene	  in	  the	  vector	  results	  in	  a	  higher	  load	  of	  this	  gene	  due	  to	  the	  multiple	  copies	  401	  
of	  the	  plasmid.	  Furthermore,	  by	  comparing	  the	  qS	  values	  of	  both	  strains,	   it	  can	  be	  clearly	  seen	  that	  the	  402	  
M15ΔglyA[pREP4]	  strain	  showed	  an	  increase	  in	  the	  specific	  glucose	  uptake	  rate	  from	  0.37	  ±	  0.04	  to	  0.50	  ±	  403	  
0.13	   gGlc·∙g-­‐1DCW·∙h-­‐1.	   As	   a	   consequence,	   the	   M15ΔglyA[pREP4]	   strain	   accumulated	   higher	   amounts	   of	  404	  
acetate	  throughout,	  reaching	  	  a	  final	  concentration	  of	  0.54	  ±	  0.03	  g·∙L-­‐1	  as	  it	  can	  be	  observed	  in	  Figure	  2D	  405	  
This	  results	  in	  higher	  acetate	  specific	  production	  rates.	  This	  is	  coherent	  with	  previous	  studies	  on	  acetate	  406	  
under	  aerobic	   conditions,	  pointing	  at	   the	  unbalance	  between	  glycolysis	   rates	   and	   the	  TCA-­‐cycle	   limited	  407	  
capacity	   of	   E.	   coli	   [20].	   Furthermore,	   it	   has	   been	   reported	   that	   the	   recombinant	   protein	   production	   is	  408	  
significantly	  reduced	  by	  acetate	  accumulation	  [21].	  Such	  effect	  can	  be	  observed	  in	  this	  study,	  were	  both	  409	  
FucA	   activity	   (AU·∙g-­‐1	   DCW)	   and	   FucA	   mass	   (mg·∙g-­‐1DCW)	   (Figure	   2B)	   decrease	   more	   than	   50	   %	   when	  410	  
comparing	  the	  M15ΔglyA[pREP4]	  strain	  to	  the	  reference	  M15[pREP4]	  (Figure	  2A).	  	  411	  
Noteworthy,	  the	  metabolic	  burden	  is	  caused	  not	  only	  due	  to	  the	  overexpression	  of	  the	  protein	  of	  interest	  412	  
but	   also	   to	   the	   expression	   of	   other	   plasmid-­‐encoded	   genes,	   that	   is,	   the	   glyA	   overexpression	  may	   also	  413	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contribute	   [22].	   In	   fact,	   the	   glyA	   gene	   encoded	   in	   the	   high-­‐copy	   plasmid	   leads	   to	   substantially	   higher	  414	  
amounts	   of	   its	   product	   (SHMT)	   accumulated	   as	   soluble	   protein	   in	   the	   cytoplasm,	   compared	   to	   the	  415	  
reference	  strain	  containing	  a	  single	  copy	  of	  glyA	  in	  the	  genome	  as	  observed	  in	  SDS-­‐PAGE	  (Figure	  2E-­‐F)	  and	  416	  
in	  Table	  1.	  The	  SHMT	  production	  (mgSHMT·∙g-­‐1DCW)	  increased	  more	  than	  4.5-­‐fold	  when	  moving	  from	  the	  417	  
M15[pREP4]	   to	   the	   M15ΔglyA[pREP4]	   strain.	   This	   observation	   suggested	   that	   glyA	   overexpression	  418	  
imposed	   a	   significant	   burden	   to	   the	   metabolism	   of	   the	   host	   cell,	   thereby	   affecting	   negatively	   FucA	  419	  
expression	  levels	  and	  the	  μmax.	  These	  preliminary	  results	  suggested	  the	  regulation	  of	  the	  glyA	  expression	  420	  
levels	   as	   an	   important	   parameter	   to	   be	   taken	   into	   account	   for	   further	   improvement	   of	   the	   expression	  421	  
system	  and	  optimization	  of	  protein	  yields.	  422	  
Interestingly,	   in	   this	  work	  we	   report	   the	   lack	   of	   FucA	   expression	   in	   the	   system	  with	   no	   lacI	   gene.	   This	  423	  
effect	  may	  be	  related	  to	  T5	  promoter	   leakiness	   in	  absence	  of	  LacI	   repressor	  protein,	   leading	  to	  plasmid	  424	  
structural	   instability	  due	  to	  recombination	  events,	  as	  supported	  by	  the	  sequencing	  data.	  Alternatively,	  a	  425	  
possible	  explanation	   for	   the	   lack	  of	  FucA	  expression	   in	   the	  single	  plasmid	  system	  may	  be	   that	   the	  copy	  426	  
number	  of	   the	   lacI	   gene	   increases	  when	   cloned	   into	   the	  pQE-­‐40	  vector,	   resulting	   in	   significantly	  higher	  427	  
levels	  of	  intracellular	  LacI.	  In	  fact,	  the	  pQE	  vector	  is	  based	  on	  the	  plasmid	  replication	  origin	  ColE1,	  which	  428	  
presents	  a	  copy	  number	  2-­‐fold	  higher	  compared	  with	  the	  P15A	  replicon	  of	  pREP4	  [1].	  	  429	  
These	   experiments	   confirmed	   that	   glyA	   and	   lacI	   co-­‐expression	   were	   required.	   Fine-­‐tuning	   the	   co-­‐430	  
expression	   of	   the	   two	   genes	   allowed	   to	   i)	   reduce	   the	   metabolic	   burden	   related	   to	   plasmid-­‐encoded	  431	  
proteins	  and,	  ii)	  optimize	  the	  regulation	  and	  induction	  of	  the	  foreign	  gene	  expression,	  when	  engineering	  432	  
parts	  of	  the	  reference	  two-­‐plasmid	  system	  into	  a	  single	  plasmid.	  433	  
For	  this	  reason,	  four	  different	  expression	  cassettes	  were	  constructed	  where	  the	  lacI	  and	  glyA	  genes	  were	  434	  
placed	  under	  the	  control	  of	  a	  set	  of	  four	  constitutive	  promoters,	  covering	  a	  wide	  range	  of	  transcriptional	  435	  
efficiencies.	  The	  resulting	  selected	  transformants	  were	  named	  M15ΔglyA[C00],	  [C11],	  [C10]	  and	  [C17]	  and	  436	  
tested	  in	  triplicate.	  The	  specific	  growth	  rate	  measured	  in	  the	  different	  cultures	  showed	  a	  similar	  behavior	  437	  
for	  all	  the	  transformants	  except	  for	  those	  with	  the	  J23100	  promoter.	  The	  strongest	  promoter,	  which	  is	  the	  438	  
one	   that	   presented	   a	   μmax	   1.3	   fold	   higher	   than	   the	   reference	   strain	   M15[pREP4]	   and	   the	   other	   three	  439	  
strains	  (Table	  2).	  Conversely,	  the	  use	  of	  a	  stronger	  constitutive	  promoter	  for	  the	  lacI	  and	  glyA	  expression	  440	  
such	  as	  the	  J23100	  resulted	  in	  low	  detection	  levels	  of	  FucA,	  both,	  in	  terms	  of	  mass	  and	  activity.	  441	  
Therefore,	   a	   higher	   growth	   rate	   could	   be	   explained	   as	   follows:	   higher	   constitutive	   lacI	   expression	   level	  442	  
may	   lead	   to	   a	   reduction	   of	   the	   fucA	   expression	   and	   subsequently	   decrease	   the	   metabolic	   burden.	  443	  
Furthermore,	   when	   comparing	   qS	   values	   during	   the	   induction	   phase,	   it	   can	   be	   clearly	   seen	   that	   the	  444	  
M15ΔglyA[C00]	  strain	  shows	  higher	  glucose	  specific	  uptake	  rate,	  being	  0.79	  ±	  0.10	  g·∙g-­‐1DCW·∙h-­‐1	  (Table	  2).	  445	  
Consistently,	   this	  strain	  resulted	   in	   the	  production	  of	   the	  highest	  yields	  of	  acetate,	   reaching	  1.50	  ±	  0.10	  446	  
gAc·∙g-­‐1DCW.	  	  447	  
According	  to	  the	  results	  shown	  in	  Figure	  3C	  and	  Table	  2,	  the	  selected	  expression	  cassette	  for	  lacI	  and	  glyA,	  448	  
was	  the	  one	  where	  both	  genes	  were	  placed	  under	  the	  control	  of	  the	  constitutive	  promoter	  J23110.	  This	  449	  
promoter,	  which	   is	   in	  the	   lower	  range	  of	  the	  tested	   lacI	  and	  glyA	   transcriptional	   levels,	  seems	  to	  down-­‐450	  
regulate	   their	   transcriptional	   levels.	   This	   suggested	   that	   the	   reduced	   expression	   of	   lacI	   and	   glyA	  451	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expression	   seems	   to	   have	   reduced	   the	   energy	   demand	   and	   the	   building	   blocks	   necessary	   for	   glyA	  452	  
synthesis.	   In	   addition,	   T5	   promoter	   leakiness	  was	  minimized,	   resulting	   in	   an	   overall	   reduced	  metabolic	  453	  
burden.	   This	   result	   is	   reflected	   in	   the	   fact	   that	   the	   μmax	   of	   this	   strain	   was	   comparable	   to	   that	   of	   the	  454	  
M15[pREP4]	   reference	   strain	   (0.48	   ±	   0.01	   h-­‐1)	   under	   pre-­‐induction	   conditions.	   Furthermore,	   the	  455	  
M15ΔglyA[C10]	  strain	  presented	  the	  lowest	  qS	  (0.44	  ±	  0.06	  g·∙g
-­‐1DCW·∙h-­‐1)	  and	  acetate	  yields	  (0.70	  ±	  0.12	  456	  
g·∙g-­‐1DCW)	   compared	   to	   the	   other	   three	   constructs	   and	   the	   highest	   FucA	   production,	   both	   in	   terms	   of	  457	  
mass,	  83	  ±	  7	  mg·∙g-­‐1DCW	  and	  activity,	  574	  ±	  49	  AU·∙g-­‐1DCW	  .	  	  458	  
Interestingly,	   FucA	   production	   values	   increased	   even	  more	   in	   the	   strain	   Puzzle	   strain	   compared	   to	   the	  459	  
previous	   system	   with	   two	   plasmids.	   In	   particular,	   while	   the	   μmax,	   being	   0.45	   	   ±	   0.01	   h
-­‐1,	   was	   still	  460	  
comparable	  to	  those	  from	  the	  preceding	  2-­‐plasmid	  construct	  and	  original	  reference	  strains	  (being	  0.48	  ±	  461	  
0.01	   h-­‐1	   and	   0.49	   ±	   0.01	   h-­‐1,	   respectively),	   the	  maximum	   FucA	  mass	   and	   FucA	   specific	   activity	   reached	  462	  
were	  162	  ±	  7	  mg-­‐1	  FucA·∙g-­‐1DCW	  and	  984	  ±	  35	  AU·∙g-­‐1DCW,	  respectively	  (Figure	  5A	  and	  Table	  3).	  Comparing	  463	  
these	  values	  with	   those	  obtained	  with	   the	  M15[pREP4]	   reference	  strain	   (181	  ±	  5	  mg	  FucA·∙g-­‐1	  DCW	  and	  464	  
721	   ±	   82	  AU·∙g-­‐1	  DCW),	   it	   can	  be	  observed	  how	   the	   specific	   activity	   increased	   1.4-­‐fold	   even	   though	   the	  465	  
amount	  of	  the	  recombinant	  protein	  was	  relatively	  lower.	  Besides,	  the	  Puzzle	  strain	  presented	  a	  reduction	  466	  
in	  the	  amount	  of	  acetate	  production,	  being	  0.42	  ±	  0.03	  g·∙g-­‐1DCW,	  in	  comparison	  with	  the	  0.73	  ±	  0.04	  g·∙g-­‐467	  
1DCW	  of	  the	  reference	  strain.	  	  468	  
These	  results	  suggest	  that	  transcriptional	  tuning	  of	   lacI	  expression	   levels	   is	  a	  key	  factor	  to	   improve	  fucA	  469	  
expression	  regulation,	  leading	  to	  a	  higher	  FucA	  specific	  activity.	  Moreover,	  the	  tuning	  of	  glyA	  levels	  has	  a	  470	  
positive	  effect	  on	  the	  reduction	  of	  the	  metabolic	  load	  due	  to	  expression	  of	  plasmid-­‐encoded	  genes	  (also	  471	  
reflected	  in	  the	  reduced	  acetate	  production).	  In	  fact,	  SHMT	  values	  were	  almost	  50%	  reduced	  comparing	  472	  
the	   Puzzle	   with	   the	   M15ΔglyA[pREP4]	   strains	   (Table	   1).	   These	   results	   are	   in	   accordance	   with	   the	  473	  
observation	   by	   Mairhofer	   et	   al.	   [23],	   who	   demonstrated	   that	   the	   folding	   machinery	   is	   severely	  474	  
overstrained	   in	   the	   plasmid-­‐based	   expression	   system	   compared	  with	   the	   plasmid-­‐free	   cells	   due	   to	   the	  475	  
different	  transcriptional	  profiles.	  476	  
Finally,	  the	  complete	  deletion	  of	  the	  antibiotic	  resistance	  gene	  has	  been	  achieved	  resulting	  in	  the	  AmpR-­‐	  477	  
strain.	   A	   slightly	   decrease	   in	   the	   μmax,	   a	   value	   of	   0.41	   ±	   0.01	   h
-­‐1	   was	   observed	   compared	   to	   the	  478	  
M15[pREP4]	  and	  Puzzle	  strains,	  which	  showed	  a	  μmax	  of	  0.49	  ±	  0.02	  h
-­‐1	  and	  0.45	  ±	  0.01	  h-­‐1,	   respectively	  479	  
(Figure	   	  6	  and	  Table	  3).	  This	   strain	  presented	  a	   significant	   increase	  both	   for	   the	  FucA	  specific	  mass	  and	  480	  
FucA	  specific	  activity.	  After	  4	  h	  of	  induction	  it	  was	  found	  maximum	  activity	  that	  corresponded	  to	  1309	  ±	  481	  
42	  AU·g-­‐1DCW	  and	  219	  ±	  5	  mgFucA·g-­‐1DCW.	  	  482	  
Comparing	  with	  all	  the	  previous	  constructs,	  FucA	  over-­‐production	  using	  the	  antibiotic	  free-­‐plasmid	  system	  483	  
is	  higher	   than	  any	  previous	  developed	  system	  studied.	   In	  particular,	  as	   it	   can	  be	  seen	   in	  Table	  3	  and	   in	  484	  
Figure	  7,	  FucA	  yields	  in	  the	  AmpR-­‐	  strain	  is:	  i)	  more	  than	  1.2-­‐fold	  higher	  comparing	  with	  the	  M15[pREP4]	  485	  
and	   the	   Puzzle	   strains;	   ii)	   2.6-­‐fold	   higher	   comparing	  with	   the	  M15ΔglyA[C10]	   strain	   and	   iii)	   three-­‐	   fold	  486	  
higher	   referred	   to	   the	  M15ΔglyA[pREP4]	   strain.	   Noteworthy,	   the	   FucA	   activity,	   in	   terms	   of	   AU·∙g-­‐1DCW,	  487	  
increased	  through	  the	  different	  stepwise	  improvements	  performed	  along	  this	  work.	  The	  best	  performing	  488	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engineered	   strain	   reached	   4.5-­‐fold	   higher	   values	   compared	   to	   the	   first	   M15ΔglyA[pREP4]	   strain.	  489	  





In	   this	   work	   we	   have	   applied	   rapid	   assembly	   strategies	   for	   the	   construction	   of	   improved	   expression	  495	  
systems	   that	   are	   useful	   for	   recombinant	   protein	   production.	   Using	   as	   a	   reference	   expression	   system	  496	  
commercially	  available,	  we	  have	  obtained	  an	  improved	  system	  that	  resulted	  in	  higher	  protein	  yields	  and	  497	  
devoid	  of	  antibiotic	  supply.	  	  498	  
This	  case-­‐study	  demonstrates	  that	  tuning	  the	  expression	  levels	  of	   lacI	  and	  glyA	  genes,	  which	  encode	  for	  499	  
the	   lac	   repressor	  and	   the	  auxotrophic	   selection	  marker	  protein,	   respectively,	   results	   into	  a	   reduction	  of	  500	  
the	  metabolic	  burden	  leading	  to	  a	  better	  stability	  of	  expression	  system.	  This	  fact	  allows	  an	  improvement	  501	  
of	  the	  recombinant	  protein	  production	  due	  to	  the	  alleviation	  of	  the	  metabolic	  burden	  and	  a	  reduction	  of	  502	  
acetate	   secretion.	   The	   main	   advantage	   of	   this	   engineered	   expression	   system	   devoid	   of	   antibiotic	  503	  
resistance	  markers	  is	  that	  it	  can	  be	  used	  as	  a	  platform	  for	  the	  production	  of	  a	  wide	  range	  of	  heterologous	  504	  
proteins	   where	   the	   use	   of	   antibiotics	   is	   restricted.	   Our	   work	   allows	   versatile	   and	   tuneable	   levels	   of	  505	  
expressed	  proteins	  at	  will,	  and	  we	  envisage	  that	  it	  can	  be	  potentially	  used	  in	  a	  wide	  range	  of	  applications	  506	  
and	  biotechnological	  processes	  with	  a	  significant	  reduction	  of	  production	  time	  and	  upstream	  costs.	  	  507	  
Nonetheless,	   to	   broaden	   the	   understanding	   and	   commercial	   exploitation	   using	   this	   novel	   expression	  508	  
platform,	   studies	   at	   bioreactor	   scale	   using	   biomass	   concentrations	   comparable	   to	   industrial	   processes	  509	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Figure	  Legends	  623	   	  624	  
Fig.	   1	   Golden	   Gate	   Assembly	   Method.	   A)	   Schematic	   diagram	   of	   Golden	   Gate	   assembly	   method	   to	  625	  
facilitate	   the	   construction	   of	   the	   new	   BioBrick	   vectors.	   C)	   Representation	   of	   the	   four	   pSB-­‐J231XX	  626	  
vectors,	  each	  one	  with	  one	  of	  the	  four	  constitutive	  promoters.	   J231XX,	  constitutive	  promoter	  where	  627	  
the	   double	   X	   represents	   the	   last	   two	   digits	   of	   the	   promoter	   name	   (J23100,	   J23111,	   J23110	   and	  628	  
J23117);	   RBS,	   ribosome	   binding	   site	   (purple	   for	   the	   lacI	   gene	   and	   pink	   for	   the	  glyA	   gene);	   lacI,	   lacI	  629	  
gene;	   glyA,	   glyA	   gene;	   term,	   termination	   sequence	   for	   the	   glyA	   gene;	   camR,	   chloramphenicol	  630	  
resistance	  gene;	  pMB1,	  replication	  origin.	  	  631	  
Fig.	  2	  A,	  B,	  C	  and	  D	  represent	  the	  profiles	  along	  time	  of	  shake	  flasks	  cultures	  performed	  per	  triplicate	  632	  
in	  DM	  media	   at	   37°C	  with	   agitation.	   (!)	   Biomass	  DCW	   (g·∙L-­‐1),(	   )	   enzyme	  activity	   (AU·∙gDCW-­‐1),	   (")	  633	  
specific	  mass	  production	  content	  (mgFucA·∙gDCW-­‐1),	  	  ( )	  Glucose	  (g·∙L-­‐1)	  and	  (	   )	  Acetic	  Acid	  (g·∙L-­‐1).	  The	  634	  
arrow	   indicates	   the	   IPTG	   pulse	   for	   the	   induction.	   E	   and	   F	   represent	   the	   SDS-­‐PAGE	   of	   shake	   flasks	  635	  
culture’s	   samples,	   where	   Lane	  M:	   molecular	   weight	   marker.	   1,	   2,	   3	   correspond	   to	   the	   shake	   flask	  636	  
culture	   replicates	   while	   the	   PI	   (pre	   induction)	   and	   1	   h,	   2h	   and	   4h	   correspond	   to	   the	   time	   after	  637	  
induction.	  The	  26	  kDa	  FucA	  and	  46	  kDa	  SHMT	  bands	  are	  indicated	  in	  the	  Figure.	  A,	  C	  and	  E	  refer	  to	  the	  638	  
M15[pREP4]	  strain	  while	  B,	  D	  and	  F	  refer	  to	  the	  M15ΔglyA[pREP4]	  strain.	  	  639	  
Fig.	   3.	   (!)	   Biomass	   DCW(g·∙L-­‐1),	   (	   )	   enzyme	   activity	   (AU·∙g-­‐1DCW)	   and	   (")	   specific	  mass	   production	  640	  
(mgFucA·∙g-­‐1DCW)	   profiles	   along	   time	   in	   defined	   media	   at	   37°C	   with	   agitation	   of	   the	   4	   different	  641	  
transformants:	   A)	   M15ΔglyA[00]	   B)	   M15ΔglyA[11]	   C)	   M15ΔglyA[10]	   D)	   M15ΔglyA[17].	   The	   arrow	  642	  
indicates	  the	  IPTG	  pulse	  for	  the	  induction.	  643	  
Fig.	   4	   ( )	  Glucose	  (g·∙L-­‐1)	  and	  ( )	  Acetic	  Acid	  (g·∙L-­‐1)	  profiles	  along	  time	   in	  defined	  media	  shake	  flasks	  644	  
cultures	  performed	  per	  triplicate	  in	  DM	  media	  at	  37°C	  with	  agitation	  of	  the	  4	  different	  transformants:	  645	  
A)	  M15ΔglyA[00]	  B)	  M15ΔglyA[11]	  C)	  M15ΔglyA[10]	  D)	  M15ΔglyA[17].	  The	  arrow	   indicates	   the	   IPTG	  646	  
pulse	  for	  the	  induction.	  647	  
Fig.	   5	   A)	   (!)	   Biomass	   DCW	   (g·∙L-­‐1),	   (	   )	   enzyme	   activity	   (AU·∙g-­‐1DCW),	   (")	   specific	   mass	   content	  648	  
(mgFucA·∙g-­‐1DCW)	  and	  B)	  ( )	  Glucose	  (g·∙L-­‐1)	  and	  (	   )	  Acetic	  Acid	  (g·∙L-­‐1)	  profiles,	  along	  time	  in	  a	  defined	  649	  
medium	  shake	  flasks	  cultures	  performed	  at	  37°C	   for	   the	  Puzzle	  strain.	  The	  arrow	   indicates	  the	  1mM	  650	  
IPTG	  pulse	  for	  the	  induction.	  	  651	  
Fig.	  6	  A)	  (!)	  Biomass	  DCW(g·∙L-­‐1),	  (	   )	  enzyme	  activity	  (AU·∙g-­‐1DCW),	  (")specific	  mass	  (mgFucA·∙g-­‐1DCW)	  652	  
and	  B)	   ( )	  Glucose	   (g·∙L-­‐1)	  and	   (	   )	  Acetic	  Acid	   (g·∙L-­‐1)	  profiles,	  along	  time	   in	  a	  defined	  medium	  shake	  653	  
flasks	  cultures	  performed	  at	  37°C	  150	  rpm	  for	  the	  AmpR-­‐	  strain.	  The	  arrow	  indicates	  the	  IPTG	  pulse	  for	  654	  
the	  induction.	  655	   	  656	  
Fig.	   7	   A)	   Maximum	   enzyme	   activity	   (AU·∙g-­‐1DCW)	   and	   B)	   Maximum	   specific	   mass	   (mgFucA·∙g-­‐1DCW)	  657	  
along	  the	  induction	  phase	  for	  the	  principal	  strains	  presented	  along	  this	  study.	  A	  dash-­‐dot	  line	  indicates	  658	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Table	   1	   SHMT	   production	   (mg·∙g-­‐1DCW)	   along	   the	   induction	   phase	   for	   the	   principal	   strains	  665	  
presented	   along	   this	   study.	   PI	   (pre	   induction)	   and	   1	   h,	   2h	   and	   4h	   correspond	   to	   the	   time	   after	  666	  
induction.	  667	  
	   M15[pREP4]	   M15ΔglyA[pREP4]	   Puzzle	   AmpR-­‐	  
PI	   27	  ±	  14	   92	  ±	  14	   66	  ±	  17	   53	  ±	  1	  
1h	   14	  ±	  1	   95	  ±	  7	   62	  ±	  10	   44	  ±	  11	  
2h	   12	  ±	  4	   91	  ±	  11	   54	  ±	  14	   48	  ±	  6	  
4h	   13	  ±	  1	   90	  ±	  14	   54	  ±	  7	   50	  ±	  10	  
 668	   Table	   2	   Maximum	   specific	   growth	   rate	   (μmax	   h-­‐1),	   FucA	   activity	   (AU·∙g-­‐1DCW),	   FucA	   mass	   (mg·∙g-­‐669	  
1DCW),	  qS	  of	  the	  induction	  phase	  and	  the	  maximum	  acetate	  yield	  (g·∙g
-­‐1DCW)	  for	  each	  of	  the	  fours	  670	  
selected	  transformants	  M15ΔglyA[C00],	  M15ΔglyA[C11],	  M15ΔglyA[C10]	  and	  M15ΔglyA[C17].	  The	  671	  
values	  represent	  the	  sample	  after	  2	  hour	  of	  induction.	  672	   	  673	  
Transformant	   μmax	  (h-­‐1)	  
FucA	  Activity	  
(AU·∙g-­‐1DCW)	  
FucA	  mass	  	  	  	  	  	  	  	  	  
(mg·∙g-­‐1DCW)	  




M15ΔglyA[C00]	   0.62	  ±	  0.05	   131	  ±	  35	   22	  ±	  9	   0.79	  ±	  0.10	   1.50	  ±	  0.10	  
M15ΔglyA[C11]	   0.37	  ±	  0.01	   233	  ±	  7	   66	  ±	  4	   0.42	  ±	  0.09	   1.12	  ±	  0.09	  
M15ΔglyA[C10]	   0.48	  ±	  0.01	   574	  ±	  49	   83	  ±	  7	   0.44	  ±	  0.06	   0.70	  ±	  0.12	  
M15ΔglyA[C17]	   0.41	  ±	  0.01	   194	  ±	  24	   50	  ±	  5	   0.58	  ±	  0.01	   1.11	  ±	  0.05	  	  674	   	  675	   Table	  3	  Maximum	  FucA	  activity	  (AU·∙g-­‐1DCW),	  maximum	  FucA	  mass	  (mg·∙g-­‐1DCW),	  μmax	  and	  maximum	  676	  
acetate	   yield	   (g·∙g-­‐1DCW)	   along	   the	   induction	   phase	   for	   the	   principal	   strains	   presented	   along	   this	  677	  
study.	  678	  
E.	  coli	  strains	   μmax	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (h-­‐1)	  
FucA	  activity	  
(AU·∙g-­‐1DCW)	  
FucA	  mass	  	  	  
(mg·∙g-­‐1DCW)	  
Acetate	  yield	  	  	  	  	  	  	  	  
(g·∙g-­‐1DCW)	  
M15[pREP4]	  	   0.49	  ±	  0.02	   721	  ±	  82	   181	  ±	  5	   0.73	  ±	  0.04	  
M15ΔglyA[pREP4]	  	   0.44	  ±	  0.01	   291	  ±	  24	   67	  ±	  37	   0.90	  ±	  0.04	  
M15ΔglyA	  [C10]	   0.48	  ±	  0.02	   574	  ±	  49	   83	  ±	  7	   0.70	  ±	  0.12	  
Puzzle	   0.45	  ±	  0.01	   984	  ±	  35	   162	  ±	  7	   0.42	  ±	  0.03	  
AmpR-­‐	   0.41	  ±	  0.01	   1309	  ±	  42	   219	  ±	  5	   0.37	  ±	  0.01	  
 679	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